Key result
Cilnidipine treatment increased the proportion of post-stroke hypertensive patients with well-controlled clinic blood pressure (<140/90 mmHg) from 21.5% at baseline to 65.3% at 12 months.
Why the study?
Does cilnidipine improve blood pressure control in Japanese post-stroke hypertensive patients?
Observational (n=2,667)
Does cilnidipine improve blood pressure control in Japanese post-stroke hypertensive patients?
Cilnidipine effectively and safely improves blood pressure control in Japanese post-stroke hypertensive patients in a real-world setting.
Answers are grounded in this paper and cite their sources.
May support cilnidipine for post-stroke BP control; hypothesis-generating pending randomized confirmation.
Blood pressure control is important in post-stroke hypertensive patients and antihypertensive treatment is recommended for such patients. Ca-channel blockers are recommended as the medications of choice for the treatment of post-stroke patients. Here, we report the results of a large-scale prospective post-marketing surveillance study of post-stroke hypertensive patients (n = 2667, male 60.4%, 69.0 ± 10.9 years) treated with cilnidipine, with regard to blood pressure control and adverse reactions. Cilnidipine treatment caused a decrease in both clinic and home blood pressures 2 months after the beginning of treatment, and the decreased blood pressure was maintained until the end of 12 months' observation. The proportion of patients in whom clinic blood pressure was well controlled (<140/90 mmHg) increased from 21.5% to 65.3% in cilnidipine treatment, with no differences in effectiveness among the various clinical subtypes of stroke. In total, 346 adverse events occurred, with an overall incidence of 8.9% (238 of 2667 patients). In the elderly group, specifically, a fall and a hip fracture each occurred in 1 (0.1%) patient. These results indicate that cilnidipine was effective in treating uncontrolled blood pressure and was well tolerated in Japanese post-stroke hypertensive patients in a real-world clinical setting.
No takes yet. Share an insight, caveat, or question.
Aoki et al. (2017) conducted an observational in post-stroke hypertension (n=2,667). Cilnidipine vs. Baseline was evaluated on clinic blood pressure well controlled (<140/90 mmHg). Cilnidipine treatment increased the proportion of post-stroke hypertensive patients with well-controlled clinic blood pressure (<140/90 mmHg) from 21.5% at baseline to 65.3% at 12 months.
Synapse has enriched 10 related papers. Consider them for comparative context: